Teva Rallies After Finding Experienced CEO, But Not Astra’s, To Take Over
Sep 11, 2017
Jeremy Parkinson
Finance
Shares of Teva Pharmaceutical (TEVA) surged in morning trading after naming a permanent chief executive officer, ending a monthlslong search for a new chief. The new CEO brings 30 years of global pharmaceutical and healthcare experience. CEO APPOINTMENT: Teva this morning said that it has named named Kare Schultz to be its new president and […]
We Didn’t Start The Fire
Sep 11, 2017
Jeremy Parkinson
Finance
What should long-duration common stock owners like us do with the news of the horrific flood in Texas, the Category 5 hurricane in the Caribbean, the heightened tensions created by North Korea’s Dictator, Kim Jong-un, and the 8.1 magnitude earthquake in Southern Mexico? What is wise behavior in a more volatile stock market environment created […]
Are CTAs Behind The Bond Rally
Sep 11, 2017
Jeremy Parkinson
Finance
Well, anyone who was frustrated with 10Y yields closing in on a 1 handle is likely a little less irritated on Monday. The broad risk-on move now has yields up some 7bps on 10s, although in the grand scheme of things, 2.12 and change probably isn’t what everyone had in mind in January when “short […]
S&P’s Irma-Relief Rally Erases “Fire & Fury” Losses
Sep 11, 2017
Jeremy Parkinson
Finance
“Fire & Fury”, Gary Cohn concerns, North Korean missiles over Japan, Hurricane Harvey, North Korean Hydrogen Bomb tests, and now Hurricane Irma… and stocks are higher… As Bob Pisani said “it just does not want to go down”.
Three Massive Bubbles In 17 Years: When Will This One Bust? A 60% Decline Coming?
Sep 11, 2017
Jeremy Parkinson
Finance
John Hussman’s presents a message no one wants to hear because nearly everyone is too busy believing for the third time in 17 years that “It’s different this time”. Last week Hussman wrote about Valuations, Sufficient Statistics, and Breathtaking Risks. This week it’s more of the same with his post Behind the Potemkin Village. The markets are […]
AUDUSD Daily Analysis – Monday, Sept. 11
Sep 11, 2017
Jeremy Parkinson
Finance
AUDUSD remains in the uptrend from 0.7807, the fall from 0.8124 is likely consolidation of the uptrend. Near-term support is located at the bullish trend line on the 4-hour chart. As long as the price is above the trend line, the upside movement could be expected to continue and next target would be at 0.8162. On […]
Irma Aftermath Puts These ETF Areas In Focus
Sep 11, 2017
Jeremy Parkinson
Finance
The effect of the highly talked-about Hurricane Irma was weaker than feared in Florida but the level of destruction was still pretty high. The cost of the storm varies from analyst to analyst. As per the guardian, “the economic cost of Hurricane Irma could rise as high as $300 billion” as it ravaged homes, businesses and […]
Jefferies Says Cryptocurrency Not A Fad, Sees No Imminent Risk For Nvidia, AMD
Sep 11, 2017
Jeremy Parkinson
Finance
While commenting on cryptocurrency exposure at both Nvidia (NVDA) and AMD (AMD), Jefferies analyst Mark Lipacis argued that the risk of a “crypo-driven” inventory correction driving material downside is low in the near-term. CRYPTOCURRENCIES NOT ‘A FAD’: In a research note this morning, Jefferies’ Lipacis told investors that he estimates cryptocurrency revenues accounted for about […]
Middle-Class Chinese Say A $1,000 IPhone Is “Too Expensive”
Sep 11, 2017
Jeremy Parkinson
Finance
Apple Inc. had hoped that its iPhone eight might demolish the company’s sales records in China as the country’s burgeoning middle class embraced the phone, thanks in part to its name: Eight is considered a lucky number in Chinese culture, signifying wealth and fortune. Unfortunately for the world’s most valuable company, this calculus isn’t playing […]
5 Top-Ranked Biotech Stocks To Buy Right Now
Sep 11, 2017
Jeremy Parkinson
Finance
Biotech stocks are back in favor thanks to two recent major developments that led to a rally in the sector. The first catalyst was Gilead Sciences’ (GILD – Free Report) announcement that it will be acquiring immunotherapy focused company, Kite Pharma (KITE – Free Report) while the FDA approval of the first gene therapy in the United States, Novartis […]